Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$11,000,000
Company Info
- Founders
- Alborz Yazdi
- Company Description
- Developing best-in-class ultra-long-acting medicines for chronic viral infections and CNS disorders, where better adherence and compliance can dramatically improve patient outcomes. Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections.
- Market
- Healthcare & Wellness
Links